Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
Conditions
Head and Neck Cancer - Esophageal Cancer
Conditions: official terms
Esophageal Neoplasms - Head and Neck Neoplasms
Conditions: Keywords
plasma circulating DNA, hean and neck cancers, esophageal cancer, localized head and neck cancers, localized esophageal cancer
Study Type
Observational
Study Phase
N/A
Study Design
Time Perspective: Longitudinal
Overall Status
Not yet recruiting
Summary
This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 90 Years
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Head and neck cancers

- Esophageal cancer

- Undergoing anti-cancer treatments

Exclusion Criteria:

- No distant metastasis
Location
Sponsors
Far Eastern Memorial Hospital
Source
Far Eastern Memorial Hospital
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page